Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 7, 2016JCI InsightOpen Access

Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease

View Full Paper
Ask AI
Bookmark
Share

Authors

NNNaoki NakagawaLBLuke BarronIGIvan G. Gomez

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nakagawa et al. (2016) studied this question.

synapsesocial.com/papers/6a7d35a3d685fe2c2d775a4ahttps://doi.org/10.1172/jci.insight.87446
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tumour necrosis factor‐α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis2011 · 57 citations
  2. 2Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis2016 · 153 citations
  3. 3Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome.1996 · 400 citations
  4. 4Regulation of the NF-κB-Mediated Transcription of Inflammatory Genes2014 · 271 citations
  5. 5Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-12008 · 209 citations